Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mutations in TP53 and ARID1A genes are common in cancer but usually exclusive. In endometrial cancer, their co-occurrence promotes aggressive, invasive adenocarcinoma by altering key cellular pathways.
Area Of Science
- Oncology
- Genetics
- Molecular Biology
Background
- TP53 and ARID1A genes are frequently mutated in various cancers, but rarely coexist within the same tumor.
- Endometrial cancer exhibits a high rate of mutual exclusivity between TP53 and ARID1A mutations.
- The functional interplay between TP53 and ARID1A mutations in endometrial development remains largely unexplored.
Purpose Of The Study
- To investigate the distinct and overlapping roles of TP53 and ARID1A mutations in endometrial cancer development.
- To elucidate the functional relationship and molecular mechanisms underlying the mutual exclusivity of TP53 and ARID1A in the endometrium.
- To determine how combined TP53 and ARID1A mutations influence endometrial tumorigenesis and progression.
Main Methods
- Utilized genetically engineered mouse models to study endometrial cancer in vivo.
- Employed genomic approaches, including transcriptome profiling of mutant endometrial epithelial cells.
- Compared gene expression patterns between TP53/PIK3CA mutant and ARID1A/PIK3CA mutant endometrium.
Main Results
- TP53 loss, alongside oncogenic PIK3CA, induced endometrial hyperplasia and adenocarcinoma.
- Both TP53 and ARID1A loss activated inflammatory pathways in PIK3CA-mutant endometrium, but with distinct gene expression profiles (e.g., epithelial-to-mesenchymal transition).
- ARID1A loss normally represses the p53 pathway; however, co-occurring TP53 and ARID1A mutations led to invasive adenocarcinoma, characterized by ATF3 induction, reduced apoptosis, and squamous differentiation.
Conclusions
- TP53 and ARID1A mutations drive both shared and unique tumorigenic programs in the endometrium.
- Simultaneous TP53 and ARID1A mutations promote invasive endometrial cancer.
- The co-occurrence of TP53 and ARID1A mutations may indicate a subset of aggressive or metastatic endometrial cancers, with ARID1A loss contributing to squamous differentiation and invasiveness.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...